| Literature DB >> 22489141 |
N Elizabeth Pryor1, Melissa A Moss2, Christa N Hestekin1.
Abstract
The aggregation of proteins into insoluble amyloid fibrils coincides with the onset of numerous diseases. An array of techniques is available to study the different stages of the amyloid aggregation process. Recently, emphasis has been placed upon the analysis of oligomeric amyloid species, which have been hypothesized to play a key role in disease progression. This paper reviews techniques utilized to study aggregation of the amyloid-β protein (Aβ) associated with Alzheimer's disease. In particular, the review focuses on techniques that provide information about the size or quantity of oligomeric Aβ species formed during the early stages of aggregation, including native-PAGE, SDS-PAGE, Western blotting, capillary electrophoresis, mass spectrometry, fluorescence correlation spectroscopy, light scattering, size exclusion chromatography, centrifugation, enzyme-linked immunosorbent assay, and dot blotting.Entities:
Keywords: Western blotting; amyloid; capillary electrophoresis; centrifugation; fluorescence correlation spectroscopy; light scattering; mass spectrometry; oligomer; polyacrylamide gel electrophoresis; size exclusion chromatography
Mesh:
Substances:
Year: 2012 PMID: 22489141 PMCID: PMC3317702 DOI: 10.3390/ijms13033038
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1The Aβ aggregation process. Aβ monomer self-assembles into low molecular weight oligomeric species that can give rise to either off-pathway oligomers or nuclei of an undetermined size. Nuclei, which arise within the rate-limiting step of the Aβ aggregation pathway, will increase in size to form high molecular weight oligomers, soluble aggregation intermediates, and finally the fibrillar aggregates that deposit in AD brain to yield amyloid plaques.
Figure 2Tricine-SDS-PAGE analysis of the aggregation states of Aβ peptides freshly dissolved or incubated for 7 days. Aβ1-42 exhibits bands at 5–20 kDa in both freshly prepared samples and samples incubated for 7 days. Aβ1-40 incubated for 7 days also exhibits a smear at higher molecular weights, which is absent in freshly prepared samples. Reprinted from [46], with permission from Elsevier.
Antibodies used for amyloid-β protein (Aβ) detection in Western blot analysis and their respective Aβ recognition motifs.
| Antibody | Recognition Motif | Monoclonal/Polyclonal | References |
|---|---|---|---|
| 6E10 | Aβ1-17 | Monoclonal | [ |
| Ab9 | Aβ1-16 | Monoclonal | [ |
| 6C6 | Aβ1-16 | Monoclonal | [ |
| 4G8 | Aβ17-24 | Monoclonal | [ |
| 2G3 | Aβ31-40 | Monoclonal | [ |
| BA-27 | Aβ1-40, C-terminal | Monoclonal | [ |
| BC-05 | Aβ1-42, C-terminal | Monoclonal | [ |
| A8 | amyloid oligomers | Monoclonal | [ |
| A11 | amyloid oligomers | Monoclonal | [ |
| NU-4 | amyloid oligomers | Monoclonal | [ |
| OC | amyloid fibrils | Polycolonal | [ |
Figure 3Aβ1-42 oligomers obtained upon incubation at 4 °C for 24 h. A 5 mM Aβ1-42 sample was prepared in DMSO and diluted to 100 μM in Ham’s F12 medium without phenol red. Oligomer mixture was separated by 15% SDS-PAGE, transferred to nitrocellulose membranes, and probed with monoclonal antibody A8 (Lanes 2 and 3) or 6E10 (Lane 4). Sample in Lane 2 was heat denatured prior to analysis, while sample in Lane 3 was untreated. Reprinted from [45] with permission. The publisher for this copyrighted material is Mary Ann Liebert, Inc. publishers.
Figure 4SDS-PAGE analysis of non-cross-linked (lanes 1 and 3) and cross-linked (lanes 2 and 4) Aβ1-40 and Aβ1-42. Densitometric intensity profiles of lanes 2 and 4 are shown on the right and left sides of the gel, respectively. Molecular weight standards are shown on the left in kDa. Adapted from [62] with permission. Copyright (2003) National Academy of Sciences, U.S.A.
Figure 5Electropherograms for Aβ1-42 species formed in room temperature PBS (pH 7.4) at different elapsed aggregation times from t0. CE was performed with 50 mbar pressure injection for 8 s with separation at 16 kV. Molecular weights corresponding to each peak were determined using Microcon centrifugal filter units with molecular weight cutoffs of 3, 10, 30, and 50 kDa. Peaks with migration times of 5–10 min represent monomers to undecamers/dodecamers (3–50 kDa) and peaks with migration times of 10–15 min represent larger aggregates (>50 kDa). Reprinted from [72] published by John Wiley and Sons, © 2004 WILEY-VCH Verlag GmbH & Co. KGaA.
Figure 6ESI-Mass spectra of 4.0 μM freshly dissolved Aβ1-40 (a and c), freshly dissolved Aβ1-40Met35(O) (b and d), Aβ1-40 and Aβ1-40Met35(O) incubated for 41 min (e and f), and Aβ1-40 and Aβ1-40Met35(O) incubated for >95 min (g and h). Aβ1-40 samples were dissolved in H2O and Aβ1-40Met35(O) samples were dissolved in H2O and 2.7% H2O2. Reprinted with permission from [98]. Copyright (2002) The American Society for Biochemistry and Molecular Biology.
Figure 7IM-MS arrival time distributions for (a) 30 μM Aβ1-42 in 49.5% H2O, 49.5% acetonitrile, and 1% NH4OH and (b) 30 μM Aβ1-40 in ammonium acetate (pH 7.4). D = dimer, Te = tetramer, H = hexamer, Do = dodecamer with a z/n = −5/2. Figure 7a adapted with permission from [103]. Copyright (2005) American Chemical Society. Figure 7b adapted by permission from Macmillan Publishers Ltd.: Nature Chemistry [104], copyright (2009).
Figure 8Size distributions obtained via FCS for Aβ1-40 dissolved in 2.8 mM NaOH, diluted to 10 μM in HEPES (pH 7.4), and incubated at room temperature. Sample taken at ~3 min shows predominantly monomeric species with the formation of intermediate aggregates of 20–100 nm after 1 h and further growth into larger aggregates >1000 nm after 24 h. Adapted with permission from [107]. Copyright (2008), American Institute of Physics.
Figure 9Time evolution of RH for a 185 μM Aβ1-40 sample incubated at pH 3.1 and 37 °C. Distributions were determined using a constrained regularization method. Reprinted with permission from [117]. Copyright (2005) The American Society for Biochemistry and Molecular Biology.
Figure 10HPLC-SEC chromatograms of Aβ aggregates produced using sample preparations of 50 μM synthetic Aβ designed to optimize (a) low molecular weight Aβ1-40 oligomers and (c) Aβ1-42 protofibrils. To ensure that insoluble fibrils were not present in solution, these species were removed via centrifugation prior to analysis, and this was confirmed by an absence of SEC signal in (b), a fibrillar Aβ1-42 preparation. Absorbance at 214 nm is given on the y-axis and retention time is given on the x-axis. Adapted from [130] published by John Wiley and Sons, © 2007 The Authors Journal Compilation © 2007 International Society for Neurochemistry.
Figure 11Aβ aggregation monitored via dot blot. A 50 μM Aβ1-40 sample was incubated in PBS (pH 7.4) at 37 °C in the presence (+) or absence (−) 3 x Brilliant Blue G (BBG) inhibitor. Samples were taken on the indicated days and spotted on a nitrocellulose membrane. Oligomer-specific A11 antibody and Aβ-sequence specific antibodies 4G8 and 6E10 were used to detect aggregates. Reprinted with permission from [57]. Copyright (2011) American Chemical Society.
Summary of techniques for the quantitative detection and/or identification of Aβ aggregate sizes formed throughout the aggregation process.
| Technique | Advantages | Disadvantages | Aggregate Sizes Detected | References |
|---|---|---|---|---|
| SDS-PAGE | SDS offers strong sizebased separation | SDS may induce non-native behavior and destabilize oligomers Gel smearing | 4.5–20 kDa, >83 kDa | [ |
| Native PAGE | Ability to separate based on charge and hydrodynamic size | Gel smearing | 8–20 kDa, high molecular weight | [ |
| Western Blotting | High sensitivity and specificity, | Requires specific and expensive antibodies Incomplete transfer of proteins onto membrane Technically demanding | 4–16 kDa, 16.5–25 kDa, 30–97 kDa (with SDS-PAGE) | [ |
| Capillary and Microfluidic Capillary Electrophoresis | Fast, highly sensitive separation of proteins based on charge and hydrodynamic size Low sample volume | Low resolution of intermediate sized Aβ oligomers Irreproducibility | 4–50 kDa, >50 kDa, fibrils | [ |
| Mass Spectrometry | Fast data acquisition Can identify multiple species with different mass-to-charge ratios | Inability to distinguish molecules with overlapping mass-to-charge ratios (MALDI, ESI) Expensive Labor intensive | 4–24 kDa, ~48 kDa, fibrils, | [ |
| Fluorescence Correlation Spectroscopy | High sensitivity, ability to look at wide range of sizes within a sample Fast analysis time Low sample volume | Relies on assumptions about shape and kinetics of protein to determine molecular weight Yields average molecular weight values | ~10 nm–1 μm (small oligomers– aggregates) | [ |
| Light Scattering | Direct measurement of molar mass and radius (MALS) Simultaneous detection of multiple populations within a sample (DLS) | Yields weight-average molar mass and not size of individual species or their distribution Exponential dependence of scattering on aggregate size | >10 kDa (MALS) | [ |
| Centrifugation | Ability to detect a wide range of sizes (oligomers–fibrils) Fast analysis time | Theoretical size estimate depends on appropriate assumptions in the model | 4–17 kDa, >250 kDa, ~270 kDa–3.8 MDa | [ |
| Size Exclusion Chromatography | Well established technique | Leads to sample dilution which can dissociate unstable oligomers Comparisons between elution behavior of oligomers and globular protein standards make molecular weight estimations difficult | 4–20 kDa, 24 kDa, >100 kDa | [ |
| Enzyme-Linked Immunosorbent Assay | Highly sensitive and specific Ability to measure specific analytes within a crude preparation Versatile | Gives information about presence of oligomers and not size Requires expensive and specific antibodies | No size determination | [ |
| Dot Blot | Straight-forward, rapid technique | Gives information about presence of oligomers and not size Requires expensive and specific antibodies | No size determination | [ |